Strategic 성장 Position Xellia as a trusted partner for high‑integrity anti-infective supply with a focus on continuity, risk management, and scalable fermentation capabilities to win more long‑term manufacturing engagements.

Global Expansion Capitalize on recent facility expansion in Cleveland and ongoing global supply capabilities to pursue regional contracts with healthcare providers, biopharma companies, and contract development/manufacturing organizations seeking reliable sourcing.

Leadership Stability Leverage the appointment of a new chief scientific officer and CEO to introduce updated partnerships, joint development opportunities, and science‑driven collaboration pitches to prospective clients.

Digital Enablement Highlight the tech stack and data‑driven operations to offer customers dashboards, real‑time supply visibility, and robust forecasting as differentiators in fermentation‑based manufacturing programs.

Portfolio Synergy Target opportunities with mid‑size pharma and specialty manufacturers looking to diversify suppliers, emphasize the secure, compliant, and scalable production of anti‑infective medicines to strengthen bids.